The Mount Sinai Health System (MSHS) https://www.mountsinai.org and the Hasso Plattner Institute (HPI) in Potsdam Germany recently formed the “Hasso Plattner Institute for Digital Health” https://hpi.de to conduct patient engaged and data driven research at Mount Sinai with a $15 million gift from the Hasso Plattner Foundation will be used to establish the new Institute
The Institute will be co-led by Joel Dudley PhD, Associate Professor of Genetics and Genomics at the Icahn School of Medicine at Mount Sinai and Director of Mount Sinai’s Institute for Next Generation Healthcare http://www.nextgenhealthcare.org, along with Erwin P. Bottinger, MD, Professor of Digital Health-Personalized Medicine at the Hasso Plattner Institute and Universitat in Potsdam Germany.
The Institute for Next Generation Healthcare (INGH) under the leadership of Dr. Dudley has developed an integrated translational biomedical research model using advances in omics, clinical medicine, digital health and artificial intelligence.
The BioMe™ BioBank Program housed at the Icahn School of Medicine enables researchers to rapidly conduct genetic, epidemiologic, molecular, and genomic studies on large collections of research specimens linked with EHRs.
The long term goals of the Institute includes:
- Establishing an organizational framework where researchers can collaborate and co-innovate seamlessly across healthcare and digital engineering
- Extending funding opportunities for researchers in the U.S and abroad
- Researching and testing prototype digital health solutions for consumers, patients, providers, and health systems in the U.S, Europe, and beyond
Additional collaborations with HPS Gesundheitscloud (HPS GC), a not-for-profit corporation funded by the Hasso Plattner Foundation, and Smart4Health, a European Union-funded research consortium, will further strengthen the Institute’s goals to develop digital solutions that will improve the health of patients worldwide.